What causes the build-up of ubiquitin-containing inclusions in Parkinson's disease?

Mechanisms of Ageing and Development

Volumn 118, Issue 1-2, 2000, Pages 15-22

  Andersen, Julie K ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Synuclein; Glutathione; Lewy bodies; Parkinson's disease; Proteosome; Ubiquitin

Indexed keywords

ALPHA SYNUCLEIN; GLUTATHIONE; PROTEASOME; UBIQUITIN;

DEGENERATIVE DISEASE; HUMAN; LEWY BODY; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW;

ANIMALS; GLUTATHIONE; HUMANS; LEWY BODIES; NERVE TISSUE PROTEINS; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN BINDING; UBIQUITINS;

PARKINSONIA;

EID: 0034283061     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(00)00150-0     Document Type: Review

References (39)

1. Alves-Rodrigues A., Gregori L., Fegueiredo-Pereira M.E. Ubiquitin, cellular inclusions and their role in neurodegeneration. Trends Neurosci. 12:1998;516-520.
2. Andersen J.K. Use of genetically engineered mice as models for exploring the role of oxidative stress in neurodegenerative disease. Front. Biosci. 3:1998;8-16.
3. Arnold J., Dawson S., Fergusson F., Lowe J., Landon M., Mayer R. Ubiquitin and its role in neurodegeneration. Van Leeuwen F.W., Salehi R.J., Giger A.J.G.D., Verhaagen J. Progress in Brain Research. 117:1998;23-34 Elsevier, Amsterdam.
4. Ciechanover A., Schwartz A.L. The ubiquitin-mediated proteolytic pathway: mechanisms of recognition of the proteolytic substrate and involvement in the degradation of native cellular proteins. FASEB J. 8:1994;182-191.
5. Conway K.A., Harper J.D., Lansbury P.T. Accelerated in vitro fibril formation by a mutant α-synuclein linked to early onset Parkinson's disease. Trends Neurosci. 21:1998;249-254.
6. Davies S.W., Turmaine M., Cozens B.A., DiFiglia M., Sharp A.H., Ross C.A., Scherzinger E., Wanker E.E., Mangiarini L., Bates G.P. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell. 90:1997;537-548.
7. Dewar D., Graham D.I., Teasdale G.M., McCulloch J. Cerebral ischemia induces alterations in tau and ubiquitin proteins. Dementia. 5:1994;168-173.
8. Feaney M.B., Bender W.W. A Drosophila model of Parkinson's disease. Nature. 404:2000;394-398.
9. Figueiredo-Pereira M.E., Yukushin S., Cohen G. Disruption of the intracellular sulfhydryl homeostasis by cadmium-induced oxidative stress leads to protein thiolation and ubiquitination in neuronal cells. J. Biol. Chem. 273:1998;12703-12709.
10. Finley D., Ozkaynak E., Varshavsky A. The yeast polyubiquitin gene is essential for resistance to high temperatures, starvation, and other stresses. Cell. 48:1987;1035-1046.
11. Hashimoto M., Hsu L.J., Xia Y., Takeda A., Sisk A., Sundsmo M., Masliah E. Oxidative stress induces amyloid-like aggregate formation of NACP/α-synuclein in vitro. Neuroreport. 10:1999;717-721.
12. Hermida-Matsumoto M.-L., Chock P.B., Curran T., Yang D.C.H. Ubiquitinylation of transcription factors c-Jun and c-Fos using reconstituted ubiquitinylating enzymes. J. Biol. Chem. 271:1996;4930-4936.
13. Il K., Ito H., Tanaka K., Hirano A. Immunocytochemical co-localization of the proteasome in ubiquitinated structures in neurodegenerative diseases and the elderly. J. Neuropathol. Exp. Neurol. 56:1997;125-131.
14. Iseki E., Odawara T., Li F., Kosaka K., Nishimura T., Akiyama H., Ikeda K. Age-related ubiquitin-positive granular structures in non-demented subjects and neurodegenerative disorders. J. Neurol. Sci. 142:1996;25-29.
15. Iwatsubo T., Yamaguchi H., Fujimuro M., Yokosawa H., Ihara Y., Trojanowski J.Q., Lee V.M. Purification and characterization of Lewy bodies from the brains of patients with diffuse Lewy body disease. Am. J. Pathol. 148:1996;1517-1529.
16. Jha N., Andersen J.K. The mechanism of action of the glutathione system in the protection of dopaminergic neurons: involvement in Parkinson's disease. Pandalai S.G. Recent Research Developments in Neurochemistry. 1999;99-108 Research Signpost, USA.
17. Jungmann J., Reins H.A., Schobert C., Jentsch S. Resistance to cadmium mediated by ubiquitin-dependent proteolysis. Nature. 361:1993;369-371.
18. Kim J. Evidence that the precursor protein of non-Ab component of Alzheimer's disease amyloid (NACP) has an extended structure primarily composed of random coil. Mol. Cells. 7:1997;78-83.
19. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile Parkinsonism. Nature. 392:1998;605-609.
20. Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., Pzuntek H., Epplen J.T., Schols L., Riess O. Ala30Pro mla30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat. Genet. 18:1998;107-108.
21. Kwak S., Masaki T., Ishiura S., Sugita H. Multicatalytic proteinase is present in Lewy bodies in neurofibrillary tangles in in diffuse Lewy body disease brains. Neurosci. Lett. 128:1991;21-24.
22. Leroy E., Boyer R., Auburger G., Leube B., Ulm G., Mezey E., Harta G., Brownstein M.J., Jonnalagada S., Chernova T., Dehejia A., Lavedan C., Gasser T., Steinbach P.J., Wilkinson K.D., Polymeropoulos M.H. The ubiquitin pathway in Parkinson's disease. Nature. 395:1998;451-452.
23. Lowe J., McDermott H., Landon M., Mayer R.J., Wilkinson K.D. Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases. J. Pathol. 161:1990;153-160.
24. Masliah E., Rockenstein E., Veinbergs I., Mallory M., Hashimoto M., Takeda A., Sagara Y., Sisk A., Mucke L. Dopaminergic loss and inclusion body formation in α-synuclein mice: implications for neurodegenerative disorders. Science. 287:2000;1265-1269.
25. Mayer R.J., Tipler C., Arnold J., Laszlo L., Al-Khedhairy A., Lowe J., Landon M. Endosome-lysosomes, ubiquitin and neurodegeneration. Adv. Exp. Med. Biol. 389:1996;261-269.
26. Mezey E., Dehejia A., Harta G., Papp M.I., Polymeropoulos M.H., Brownstein M.J. α-Synuclein in neurodegenerative disorders: murderer or accomplice? Nat. Med. 4:1998;755-757.
27. Mimnaugh E.G., Bonvini P., Neckers L. The measurement of ubiquitin and ubiquinated proteins. Electrophoresis. 20:1999;418-428.
28. Muller S., Lawrence L.M. Ubiquitin in homeostasis, development and disease. Bioessays. 17:1995;677-684.
29. Narhi L., Wood S.J., Steavonson S., Jiang Y., Wu G.M., Anafi D., Kaufman S.A., Martin F., Sitney K., Denis P., Loius J.C., Wypych J., Biere A.L., Citron M. Both familial Parkinson's mutations accelerate α-synuclein aggregation. J. Biol. Chem. 274:1999;9843-9846.
30. Obin M., Shang F., Gong X., Handelman G., Blumberg J., Taylor A. Redox regulation of ubiquitin-conjugating enzymes: mechanistic insights using the thiol-specific oxidant diamide. FASEB J. 12:1998;561-569.
31. Pirim I. Production of anti-polyubiquitin and anti-ubiquitin carboxyl terminal hydrolase antibodies and immunohistochemically assessment of them on brain sections of Alzheimer's disease and Lewy body disease. Int. J. Neurosci. 95:1998;33-42.
32. Polymeropoulos M.H., Lavedant C., Leroy E., Ide S., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papaetropulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science. 276:1997;2045-2047.
33. Schwartz A.L., Ciwchanover A., Brandt R.A., Gueze H.J. Immunoelectron microscope localization of ubiquitin in hepatoma cells. EMBO J. 7:1988;2961-2966.
34. Shang F., Gong X., Taylor A. Activity of ubiquitin-dependent pathway in response to oxidative stress. J. Biol. Chem. 272:1997;23086-23093.
35. Shimura H., Hattori N., Kubo S., Mizuno Y., Asakawa S., Minoshima S., Shimizu N., Iwai K., Chiba T., Tanaka K., Suzuki T. Familial Parkinson disease gene product, parkin, is a ubiquitin ligase. Nature Gen. 25:2000;302-305.
36. Spillantini M.G., Schmidt M.L., Lee V.M.-Y., Trojanowski J.Q., Jakes R., Goedert M. α-Synuclein in Lewy bodies. Nature. 388:1997;839-840.
37. Uney J.B., Anderton B.H., Thomas S.M. Changes in heat shock protein 70 and ubiquitin mRNA levels in C1300 N2A mouse neuroblastoma cells following treatment with iron. J. Neurochem. 60:1993;659-665.
38. Weinreb P.H., Zhen W., Poon A.W., Conway K.A., Lansbury P.T. Jr NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry. 35:1996;13709-13715.
39. Wilkinson K.D. Regulation of ubiquitin-dependent processes by deubiquitinating enzymes. FASEB J. 11:1997;1245-1256.